Retroperitoneal Lymph Node Dissection in Patients with Stage II Seminomatous Germ Cell Tumour.
Eur Urol Focus
; 10(3): 361-363, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-39095218
ABSTRACT
Treatment de-escalation strategies in patients with seminoma with retroperitoneal metastases are being investigated in ongoing clinical trials. Primary retroperitoneal lymph node dissection conducted by expert surgeons may avoid any cytotoxic treatment and related long-term side effects in ≥70% of patients with clinical stage IIA/B seminoma.
Full text:
1
Database:
MEDLINE
Main subject:
Testicular Neoplasms
/
Seminoma
/
Lymph Node Excision
/
Neoplasm Staging
Limits:
Humans
/
Male
Language:
En
Journal:
Eur Urol Focus
Year:
2024
Type:
Article